Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migraine chronification and reversibility withdrawal trial
2011-005124-18Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in chronic migraine, medication overuse headache (MOH), sponsored by Leiden University Medical Center. Started May 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migrainemedication overuse headache (MOH)
Beyond the preview
Go deeper on 2011-005124-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005124-18.